| Stellar Resources Limited (SRZ) ORDINARY FULLY PAID |
Materials |
$95 |
Queen Hill Resource Up 41%
|
23 Feb 2026 9:46AM |
$0.031 |
$0.035 |
risen by
12.90%
|
|
SRZ - Price-sensitive ASX Announcement
Full Release
Key Points
- Queen Hill Resource increased by 41%
- Heemskirk Tin Project contains over 100,000 tonnes of tin
- One of the highest-grade undeveloped tin projects globally
- Updated MRE prepared by Haren Consulting
- Lower cut-off grade used for resource estimation
- Prefeasibility Study scheduled for completion by mid-2026
- Ongoing drilling to update Severn Resource
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Metal Bank Limited (MBK) ORDINARY FULLY PAID |
Materials |
$22 |
High-Grade Near-Surface Graphite Intersected at Millennium
|
23 Feb 2026 9:46AM |
$0.027 |
$0.026 |
fallen by
3.70%
|
|
MBK - Price-sensitive ASX Announcement
Full Release
Key Points
- High-grade near-surface graphite intersected at Millennium Project.
- Drilling confirmed significant graphite mineralisation adjacent to existing pit design.
- Assays include 13.1m @ 12.23% TGC from 1m in drill hole MI25DD03.
- Graphite mineralisation extends over more than 2km strike.
- Potential low-strip ratio development opportunity for graphite discovered.
- Preliminary metallurgical work on graphite samples has commenced.
- Further drilling and metallurgical assessments planned to enhance project understanding.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| TZ Limited (TZL) ORDINARY FULLY PAID |
Information Technology |
$12 |
Amended Appendix 4C for the Quarter Ended 31 December 2025
|
23 Feb 2026 9:45AM |
$0.042 |
$0.039 |
fallen by
7.14%
|
|
TZL - Price-sensitive ASX Announcement
Full Release
Key Points
- Amended Appendix 4C for the quarter ended 31 December 2025.
- Correction of significant receipt of AU$350,000 received post-quarter.
- Expectations for improved operating cash flows in the second half of FY26.
- Causeway Finance facility details corrected.
- Initiatives to establish a trade finance/factoring facility.
- Board expects continued operations based on financial strategies.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| WAM Active Limited (WAA) ORDINARY FULLY PAID |
Financials |
$146 |
Oversubscribed Entitlement Offer and Placement raises $70.7
|
23 Feb 2026 9:45AM |
$1.025 |
$0.985 |
fallen by
3.90%
|
|
WAA - Price-sensitive ASX Announcement
Full Release
Key Points
- WAM Active Limited (ASX: WAA) conducted a 2 for 3 pro-rata non-renounceable Entitlement Offer.
- The Entitlement Offer closed oversubscribed, raising a total of $70.7 million.
- The Offer comprised $25.3 million from the Entitlement Offer and Top-Up Facility, and $45.4 million expected from the Shortfall Offer and Placement.
- Eligible directors of WAM Active applied for their full entitlements.
- The Company also undertook a $19.3 million institutional placement to accommodate investor demand.
- The increased capital improves share liquidity, reduces the fixed expense ratio, and enhances market presence.
- Proceeds will be invested using WAM Active's investment approach, focusing on market mispricing opportunities.
- The Entitlement Offer increases WAM Active's assets by 84% to over $154.8 million.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Lumos Diagnostics Holdings Limited (LDX) ORDINARY FULLY PAID |
Health Care |
$223 |
Lumos Completes Enrolment Milestone for Paediatric Study
|
23 Feb 2026 9:45AM |
$0.280 |
$0.280 |
fallen by
0%
|
|
LDX - Price-sensitive ASX Announcement
Full Release
Key Points
- Lumos completed Milestone 6 in its BARDA-funded paediatric clinical study.
- The completion triggers a US$720,000 payment.
- Total milestone payments received to-date amount to US$1,920,000.
- BARDA's non-dilutive funding totals US$6,198,459 for all 12 milestones.
- The study aims to broaden FebriDx® use in the U.S. to include patients aged 2-64 years.
- The paediatric study assesses FebriDx® use for children 2-12 years old.
- FebriDx® is currently FDA 510(k)-cleared for patients 12-64 years.
- FebriDx® could expand to 270,000 clinical sites with a CLIA waiver.
- The expansion could increase market size 15-fold to over US$1.0 billion.
- The announcement was approved by the Lumos Disclosure Committee.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Neurotech International Limited (NTI) ORDINARY FULLY PAID |
Health Care |
$16 |
Positive 90-day GLP toxicology study results in non-rodents
|
23 Feb 2026 9:45AM |
$0.014 |
$0.012 |
fallen by
14.29%
|
|
NTI - Price-sensitive ASX Announcement
Full Release
Key Points
- NTI164 demonstrated a favourable safety profile in a 90-day GLP toxicology study.
- The study was conducted in non-rodent species, specifically Beagle dogs.
- NTI164 was well tolerated at doses up to 216 mg/kg/day, which is approximately ten times the highest prescribed human dose.
- No mortality or dose-limiting toxicities were observed during the study.
- The study included additional assessments focused on the central nervous system, guided by the FDA.
- Mild and reversible treatment-related findings were observed, with full recovery after a 14-day non-dosing period.
- The results support the continued clinical development of NTI164 as a potential chronic therapy for neurological disorders.
- The study strengthens the safety package required for future regulatory interactions and clinical development.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| DigitalX Limited (DCC) ORDINARY FULLY PAID |
Information Technology |
$45 |
DCC to Establish Strategic Acquisition Program
|
23 Feb 2026 9:45AM |
$0.032 |
$0.030 |
fallen by
6.25%
|
|
DCC - Price-sensitive ASX Announcement
Full Release
Key Points
- Establishment of strategic investment acquisition program up to A$30 million.
- Focus on digital asset infrastructure and Bitcoin-aligned opportunities.
- Program funded from existing asset base and balance sheet.
- All investments to undergo Board approval and due diligence.
- Strategic shift to enhance balance sheet productivity and value creation.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Close the Loop Ltd (CLG) ORDINARY FULLY PAID |
Industrials |
$14 |
1H26 Results Update
|
23 Feb 2026 9:45AM |
$0.031 |
$0.027 |
fallen by
12.90%
|
|
CLG - Price-sensitive ASX Announcement
Full Release
Key Points
- Close the Loop Ltd reported a revenue increase to AUD 92.3 million in 1H26.
- Underlying EBITDA and NPATA fell by 23% and 61% respectively.
- Operational challenges in North America impacted performance.
- The Mexicali facility ramp-up is improving efficiencies.
- Packaging division experienced strong growth and resilience.
- Strategic divestment of non-core assets like Alliance Paper Pty Ltd.
- Focus remains on core cash-generative businesses.
- Debt increased but restructuring efforts are underway for sustainability.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Aurelia Metals Limited (AMI) ORDINARY FULLY PAID |
Materials |
$465 |
Initial Director's Interest Notice - Hunt
|
23 Feb 2026 9:44AM |
$0.290 |
$0.275 |
fallen by
5.17%
|
|
| Rhythm Biosciences Limited (RHY) ORDINARY FULLY PAID |
Health Care |
$69 |
Trading Halt
|
23 Feb 2026 9:44AM |
$0.205 |
$0.210 |
risen by
2.44%
|
|
RHY - Price-sensitive ASX Announcement
Full Release
Key Points
- Rhythm Biosciences Limited (ASX: RHY) requested a trading halt.
- The trading halt is pending the release of an announcement by RHY.
- The announcement is related to a proposed underwriting agreement concerning the company's outstanding RHYO options.
- The trading halt will last until the announcement is made or until the market opens on Wednesday, 25 February 2026.
- RHY is not aware of any reason why the trading halt request should not be granted.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Atomo Diagnostics Limited (AT1) ORDINARY FULLY PAID |
Health Care |
$29 |
Investor Webinar Presentation
|
23 Feb 2026 9:44AM |
$0.037 |
$0.036 |
fallen by
2.70%
|
|
| Tartana Minerals Limited (TAT) ORDINARY FULLY PAID |
Materials |
$8 |
Tartana Corporate Update - February 2026
|
23 Feb 2026 9:44AM |
$0.038 |
$0.030 |
fallen by
21.05%
|
|
TAT - Price-sensitive ASX Announcement
Full Release
Key Points
- Tartana Minerals Limited focuses on multi-asset exploration around Tartana Mine.
- Key projects include Nightflower Silver and Montalbion Silver Projects.
- Development of gold and copper projects at Mountain Maid and Cardross.
- Plan to conduct 10,000 meters of drilling in 2026.
- Joint ventures and financing explored for plant expansion.
- Defined JORC mineral resources and further drilling to upgrade estimates.
- Financial activities include placements and convertible notes.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Energy Action Limited (EAX) ORDINARY FULLY PAID |
Industrials |
$17 |
Final Director's Interest Notice
|
23 Feb 2026 9:44AM |
$0.480 |
$0.430 |
fallen by
10.42%
|
|
| Close the Loop Ltd (CLG) ORDINARY FULLY PAID |
Industrials |
$14 |
Half Yearly Report and Accounts
|
23 Feb 2026 9:43AM |
$0.031 |
$0.027 |
fallen by
12.90%
|
|
CLG - Price-sensitive ASX Announcement
Full Release
Key Points
- Net loss from continuing operations was $26,878,000.
- Continuing operations revenue was $92,306,000.
- Gross margin improved to 34.9%.
- Significant divestments of Alliance Paper Pty Ltd and O F Flexo Pty Ltd.
- Company remains focused on zero waste to landfill and circular economy.
- Reduction in EBITDA by 23% compared to the previous period.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Genesis Energy Limited (GNE) ORDINARY FULLY PAID FOREIGN EXEMPT NZX |
Utilities |
$2,069 |
Appendix 3B
|
23 Feb 2026 9:43AM |
$2.050 |
$1.790 |
fallen by
12.68%
|
|
| Regal Investment Fund (RF1) ORDINARY UNITS FULLY PAID |
Financials |
$735 |
Weekly Estimate NTA for 20.02.2026
|
23 Feb 2026 9:43AM |
$3.550 |
$3.500 |
fallen by
1.41%
|
|
| Gorilla Gold Mines Ltd (GG8) ORDINARY FULLY PAID |
Materials |
$278 |
Thick Drilling Intercepts at Comet Vale
|
23 Feb 2026 9:43AM |
$0.435 |
$0.380 |
fallen by
12.64%
|
|
GG8 - Price-sensitive ASX Announcement
Full Release
Key Points
- Significant new drilling results at Comet Vale Gold Project.
- Notable intercept of 49 meters at 2.5 g/t Au at Sovereign Deposit.
- Thickest mineralization result to date, representing a key exploration target.
- Additional drilling results include 4.8 meters at 20.1 g/t Au.
- 750,000 ounces added to resources in 2025.
- Three drill rigs at Comet Vale and two at Mulwarrie Project.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Genesis Energy Limited (GNE) ORDINARY FULLY PAID FOREIGN EXEMPT NZX |
Utilities |
$2,069 |
Appendix 3A.1
|
23 Feb 2026 9:43AM |
$2.050 |
$1.790 |
fallen by
12.68%
|
|
| Butn Limited (BTN) ORDINARY FULLY PAID |
Financials |
$14 |
Financial Results - 31 December 2025
|
23 Feb 2026 9:41AM |
$0.055 |
$0.037 |
fallen by
32.73%
|
|
BTN - Price-sensitive ASX Announcement
Full Release
Key Points
- Platform originations reached a record $113.9 million, a 38% increase compared to the prior corresponding period.
- Revenue for the half-year ending 31 December 2025 was $8.2 million, a 15% increase from $7.1 million in the previous corresponding period.
- The company reported an underlying net loss after tax of approximately $1.5 million, with a statutory loss after tax of $1.9 million.
- A $100 million senior debt facility was established with Northleaf Capital Partners, with $77 million already drawn.
- In September 2025, Stanley Gordon was appointed as an Independent Non-Executive Director.
- The company completed a $3 million equity placement as part of a $10 million raise announced in July 2025.
- Butn Limited is exploring growth opportunities, including the establishment of the Moneybox retail private credit fund and entry into the APAC crypto-backed lending market.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Toubani Resources Inc (TRE) ORDINARY FULLY PAID |
Materials |
$339 |
Environmental Permit for Kobada Received
|
23 Feb 2026 9:40AM |
$0.465 |
$0.450 |
fallen by
3.23%
|
|
TRE - Price-sensitive ASX Announcement
Full Release
Key Points
- Toubani Resources received environmental permit for Kobada Gold Project.
- The permit covers the Environmental and Social Impact Assessment and Resettlement Action Plan.
- All necessary permits for construction of the Kobada Gold Project are now acquired.
- Resettlement activities have begun in line with the project schedule.
- Toubani Resources is focused on advancing large gold development projects in Africa.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Micro-X Limited (MX1) ORDINARY FULLY PAID |
Health Care |
$47 |
MX1 - Response to Publication on Government Website
|
23 Feb 2026 9:40AM |
$0.070 |
$0.065 |
fallen by
7.14%
|
|
MX1 - Price-sensitive ASX Announcement
Full Release
Key Points
- Micro-X Ltd has been named as a project partner for a $1.5M technology development grant.
- The company is in advanced stages of finalizing a development contract but has not yet fully executed it.
- Micro-X specializes in cold cathode X-ray technology for health and security markets.
- The company's products include mobile digital radiology and a miniature brain CT imager.
- Micro-X is working with the US Department of Homeland Security on next-generation security checkpoints.
- The company has a design and production facility in Adelaide, Australia, and a commercial team in Seattle.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Osteopore Limited (OSX) ORDINARY FULLY PAID |
Health Care |
$4 |
OSX and TTSH secure additional funding for novel implant
|
23 Feb 2026 9:40AM |
$0.008 |
$0.007 |
fallen by
12.50%
|
|
| Genesis Energy Limited (GNE) ORDINARY FULLY PAID FOREIGN EXEMPT NZX |
Utilities |
$2,069 |
Trading Halt
|
23 Feb 2026 9:39AM |
$2.050 |
$1.790 |
fallen by
12.68%
|
|
GNE - Price-sensitive ASX Announcement
Full Release
Key Points
- Genesis Energy plans to raise approximately NZ$400 million.
- The capital raising includes a NZ$100 million placement and a NZ$300 million rights offer.
- The New Zealand government will maintain a 51% shareholding.
- A trading halt is requested from 23 February 2026.
- The halt will be lifted after the placement results or by 24 February 2026.
- Jarden Securities Limited will conduct the placement.
- The purpose of the halt is to ensure market orderliness and transparency.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Cygnus Metals Limited (CY5) ORDINARY FULLY PAID |
Materials |
$170 |
New drilling and geophysics programs commenced
|
23 Feb 2026 9:39AM |
$0.175 |
$0.160 |
fallen by
8.57%
|
|
CY5 - Price-sensitive ASX Announcement
Full Release
Key Points
- Drilling commenced at Golden Eye to grow the indicated resource.
- Induced Polarisation survey underway at Joe Mann.
- Permits submitted for drilling at Gwillim, co-funded by Alamos Gold.
- Cygnus targets resource growth with a focus on brownfields exploration.
- Potential for substantial resource growth at Chibougamau.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Locksley Resources Limited (LKY) ORDINARY FULLY PAID |
Materials |
$70 |
LKY Commences Diamond Drilling at Desert Antimony Mine
|
23 Feb 2026 9:39AM |
$0.165 |
$0.190 |
risen by
15.15%
|
|
LKY - Price-sensitive ASX Announcement
Full Release
Key Points
- Diamond drilling commenced at Desert Antimony Mine.
- Targets extensions of known high-grade stibnite mineralization.
- Program supports U.S. critical materials supply chain priorities.
- Collaboration with Rice University and U.S. Department of Energy.
- Part of Locksley’s strategy for re-establishing U.S. antimony supply.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Call 1300 880 160
Start a chat
Schedule a call
